{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-22-000089","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2022-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.748285+00:00","generated_at":"2026-06-24T08:53:54.013355+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Stryker Q2 organic sales +6.1% to $4.5B; lowers FY adjusted EPS guidance to $9.30-$9.50","bullets":["Reported net sales of $4.5B (+4.6% YoY); organic net sales +6.1%.","Reported EPS $1.72 (+11%); adjusted EPS of $2.25 flat YoY.","MedSurg & Neurotechnology organic sales +7.9%; Orthopaedics & Spine organic +3.9%.","Adjusted operating margin contracted 220 bps to 23.7%; FY22 organic sales guidance raised to 8-9%."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-22-000089","json":"https://secwatch.observer/filing/0000310764-22-000089.json","markdown":"https://secwatch.observer/filing/0000310764-22-000089.md","text":"https://secwatch.observer/filing/0000310764-22-000089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076422000089/0000310764-22-000089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076422000089/syk-20220726.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T08:53:54.013355+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}